Gain Therapeutics Inc. (GANX) at a glance

Gain Therapeutics Inc. (GANX) is a micro-cap Healthcare company. It trades at $1.75, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 44/100 overall. Its strongest dimension is Value (50/100) and its weakest is Momentum (21/100).

Price
$1.75
Market cap
$71.7M
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$1.41 to $4.34
Vestovix Score44/ 100How this works
Value
50
Growth
50
Income
40
Safety
46
Momentum
21

Other Healthcare stocks

See all